Cargando…
Role of Antiplatelet Therapy in Patients with Severe Coronary Artery Disease Undergoing Coronary Artery Endarterectomy within Coronary Artery Bypass Surgery Ψ
Background—Coronary endarterectomy (CEA) has been introduced to allow revascularization in end-stage coronary artery disease (CAD). After CEA, the injured remnants of the vessel’s media could result in fast neo intimal tissue ingrowth, which require an anti-proliferation agent (antiplatelet therapy...
Autores principales: | Balaj, Ilir, Jakob, Heinz, Haddad, Ali, Mourad, Fanar, Haneya, Assad, Ali, Ebrahim, Ryadi, Noura, Thielmann, Matthias, Ruhparwar, Arjang, Shehada, Sharaf-Eldin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051999/ https://www.ncbi.nlm.nih.gov/pubmed/36975876 http://dx.doi.org/10.3390/jcdd10030112 |
Ejemplares similares
-
Outcomes of Patients Undergoing Closed Traction Coronary Endarterectomy: A Long-Term Single Center Study †
por: Shehada, Sharaf-Eldin, et al.
Publicado: (2022) -
Impact of Non-Valvular Non-Coronary Concomitant Procedures on Outcomes of Surgical Aortic Valve Replacement in Intermediate Risk Patients
por: Mourad, Fanar, et al.
Publicado: (2021) -
Coronary endarterectomy for diffusely diseased coronary artery: An ace in the hole in coronary artery surgery
por: Nishigawa, Kosaku, et al.
Publicado: (2021) -
Early results of coronary artery bypass grafting with coronary endarterectomy for severe coronary artery disease
por: Schmitto, Jan D, et al.
Publicado: (2009) -
Comparison of dual antiplatelet therapies after coronary endarterectomy combined with coronary artery bypass grafting: a cohort study
por: Yan, Hua, et al.
Publicado: (2020)